Luspatercept, sold under the brand name Reblozyl, is a medication used for the treatment of anemia in beta thalassemia and myelodysplastic syndromes.
Luspatercept, sold under the brand name Reblozyl, is a medication used for the treatment of anemia in beta thalassemia and myelodysplastic syndromes.
The US Food and Drug Administration (FDA) considers it to be a first-in-class medication.
Discovered by embedding cosine similarity (sentence-transformers MiniLM, 384-dim).